CXCL12 and B-cell chronic lymphocytic leukemia: Spiegelmer NOX-A12, targeting CXCL12, interferes with the migration and drug resistance of chronic lymphocytic leukemia (CLL), inhibits chemotaxis, and sensitizes CLL cells to cytotoxic drugs [70].